Managed care interface
-
Managed care interface · Jan 2002
Just what the doctor ordered: avoiding kickback pitfalls with prescription drugs.
Risks associated with the federal antikickback statute increased significantly for the pharmaceutical industry in the 1990s. Manufacturers, physicians, and MCOs must take account of the statute when developing programs that could possibly implicate it. This article provides guidance to the managed care community regarding legal kickback risks in arrangements with pharmaceutical manufacturers.